Live Breaking News & Updates on Ntx

Stay updated with breaking news from Ntx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

BioNTech Announces First Quarter 2024 Financial Results and

Advancing toward goal of ten or more potentially registrational trials running by the end of 2024: first patient dosed in Phase 3 clinical trial evaluating. ....

United States , James Ryan , Annemarie Hanekamp , Sean Marett , Biontech Fixvac , Ugur Sahin , Fosun Pharma , Jens Holstein , Genmabas Genmab , Biotheus Inc , Roche Group Genentech , Genentech Inc , Pfizer Inc , American Association For Cancer Research , Biontech Group , Instadeep Ltd , Drug Administration , German Central Bank Deutsche Bundesbank , Medilink Therapeutics Suzhou Co Ltd , Exchange Commission , Influenza Combination Vaccine Program , Company Management Board , Duality Biologics Suzhou Co , Roche Group , American Society Of Clinical Oncology , Biontech Innovative Manufacturing Services Gmb ,

Three-year Phase 1 Follow-Up Data for mRNA-based

Three-year follow-up data of an investigator-initiated Phase 1 trial of the individualized mRNA cancer vaccine candidate autogene cevumeran (BNT122,. ....

United States , San Diego , Vinod Balachandran , Fosun Pharma , American Association For Cancer Research , Roche Group , Memorial Sloan Kettering Cancer Center , Chief Medical Officer , American Association , Cancer Research , Annual Meeting , Good Manufacturing Practice , New Technologies , Private Securities Litigation Reform Act , Annual Report , Nasdaq Bntx , Biontech Se , Clinical Trial , Pancreatic Cancer , Linische Studie , Auchspeicheldr 252 Senkrebs ,

BNTX DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL,

NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioNTech SE. ....

New York , United States , Phillip Kim , Laurence Rosen , Securities Class Action Services , Chinese Company , Pfizer Inc , Rosen Law Firm , Class Period , Law Firm , Class Action Services , Class Has Been , The Rosen Law Firm Pa , Biontech Se , Lass Action ,

BIONTECH SHAREHOLDER NOTICE: Faruqi & Faruqi Securities

If you suffered losses exceeding $100,000 investing in BioNTech stock or options between March 30, 2022 and October 13, 2023 and would like to discuss your. ....

United States , New York , Josh Wilson , Drug Administration , Wilson Faruqi , Class Period , American Depositary Share , Third Bridge , Goods Sold , Faruqi Amp Llp , Aruqi Amp Faruqi , Aruqi Law , Lass Action , Class Action Lawsuit , Biontech Se ,

BNTX DEADLINE ALERT: ROSEN, TRUSTED INVESTOR COUNSEL,

NEW YORK, Feb. 23, 2024 (GLOBE NEWSWIRE) WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioNTech SE. ....

New York , United States , Phillip Kim , Laurence Rosen , Chinese Company , Rosen Law Firm , Securities Class Action Services , Pfizer Inc , Class Period , Law Firm , Class Action Services , Class Has Been , The Rosen Law Firm Pa , Biontech Se , Lass Action ,